Overview

A Dose Ranging Vehicle Controlled Study to Determine the Safety and Efficacy of Permethrin Foam, 5% and Permethrin Foam, 4% for the Treatment of Scabies

Status:
Completed
Trial end date:
2014-12-01
Target enrollment:
Participant gender:
Summary
To determine and compare the safety and efficacy of permethrin foam 4% and permethrin foam 5% with that of vehicle in subjects with scabies.
Phase:
Phase 2
Details
Lead Sponsor:
Mylan Inc.
Renaissance Pharma, Inc.
Collaborators:
DPT Laboratories, Ltd.
Vyne Therapeutics Inc.
Treatments:
Permethrin